Uncategorised - European Medical Journal

Predicting Rheumatoid Arthritis Using the Symptoms in Persons at Risk of Rheumatoid Arthritis (SPARRA) Questionnaire

Accurate prediction of rheumatoid arthritis (RA) development in persons at risk of RA can help to select individuals for early intervention trials…

Latest Highlights on Biologic Treatments for Psoriatic Arthritis from EULAR 2020

Psoriatic arthritis (PsA) is a chronic, heterogeneous, immune-mediated arthritis characterised by joint inflammation and diverse clinical manifestations…

Are Coping Strategies, Anxiety, and Depression Associated with Daily Physical Activity in Patients With Axial Spondyloarthritis?

Patients with axial spondyloarthritis (axSpA) who are more physically active experience less pain and better physical functioning…

EULAR 2020 Interview: Ms Sue Oliver OBE

When I started my masters, I think that I was always keen to have a role where I could make a bit of a difference and so finding a way to do that felt right…

Interview: Clinical Prof Daniel Wallace

Clinical Prof Daniel Wallace | Rheumatologist, Cedars-Sinai Medical Center and Ronald Reagan UCLA Medical Center, Los Angeles, California, USA…

Early Recognition and Treatment of Spondyloarthritis: A Timeless Challenge

Spondyloarthritis (SpA) is a chronic systemic rheumatic disease, the hallmark manifestation of which is inflammatory back pain, and may also involve…

Improving Risk-Stratification of Patients with Rheumatoid Arthritis for Interstitial Lung Disease

Interstitial lung disease (ILD) is a common pulmonary manifestation of rheumatoid arthritis (RA). It has emerged in recent studies as a key prognostic…

2019 Update of the Joint European League Against Rheumatism (EULAR) and European Renal Association–European Dialysis and Transplant Association (ERA-EDTA) Recommendations for the Management of Lupus Nephritis

A significant proportion of patients with systemic lupus erythematosus develop renal disease, which has a major impact on the course of the disease…

Editor’s Pick: Methotrexate and The Lung in Rheumatoid Arthritis

Methotrexate (MTX) is the most commonly used medication to treat RA. MTX pneumonitis (MTX-pneu) is a rare disease entity reported in MTX users.

Using Educational Applications to Facilitate Understanding of the Anatomy and Function of the Brain and Explore the Effects of Clinical Fatigue as from the Patient Perspective

When discussing the impact of rheumatic disease states with patients living with these conditions, fatigue is often at the forefront of that discussion…